00866nas a2200217   4500000000100000008004100001260001600042653002300058653002200081653002100103653001900124653002000143653001700163653001700180100001400197700001700211700001400228245005700242520033500299022001400634       2024                            d  bElsevier BV10aNeglected Diseases10aZoonotic diseases10aDrug repurposing10aDrug Discovery10aPharmaceuticals10aEpidemiology10aPharmacology1 aMentis AA1 aHernandez HW1 aKaitin KI00aDrug repurposing for neglected and zoonotic diseases3 a<p>Globalization and climate change have intensified the need to address the marginalization of R&amp;D for neglected and zoonotic diseases. We propose that drug repurposing, using enabling technologies such as artificial intelligence, can address this need at a lower cost than&nbsp;<em>de novo</em>&nbsp;R&amp;D processes.</p>
  a0165-6147